| Use of florbetapir-PET for imaging β-amyloid pathology CM Clark, JA Schneider, BJ Bedell, TG Beach, WB Bilker, MA Mintun, ... Jama 305 (3), 275-283, 2011 | 1207 | 2011 |
| Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-β plaques: a prospective cohort study CM Clark, MJ Pontecorvo, TG Beach, BJ Bedell, RE Coleman, ... The Lancet Neurology 11 (8), 669-678, 2012 | 841 | 2012 |
| In vivo imaging of amyloid deposition in Alzheimer disease using the radioligand 18F-AV-45 (flobetapir F 18) DF Wong, PB Rosenberg, Y Zhou, A Kumar, V Raymont, HT Ravert, ... Journal of nuclear medicine 51 (6), 913-920, 2010 | 773 | 2010 |
| The Centiloid Project: standardizing quantitative amyloid plaque estimation by PET WE Klunk, RA Koeppe, JC Price, TL Benzinger, MD Devous Sr, WJ Jagust, ... Alzheimer's & dementia 11 (1), 1-15. e4, 2015 | 707 | 2015 |
| The cholinergic hypothesis: a historical overview, current perspective, and future directions. RT Bartus, RL Dean, MJ Pontecorvo, C Flicker Annals of the New York Academy of Sciences, 1985 | 553 | 1985 |
| Four distinct trajectories of tau deposition identified in Alzheimer’s disease JW Vogel, AL Young, NP Oxtoby, R Smith, R Ossenkoppele, ... Nature medicine 27 (5), 871-881, 2021 | 433 | 2021 |
| Phase 3 solanezumab trials: secondary outcomes in mild Alzheimer's disease patients ER Siemers, KL Sundell, C Carlson, M Case, G Sethuraman, H Liu-Seifert, ... Alzheimer's & Dementia 12 (2), 110-120, 2016 | 426 | 2016 |
| Amyloid-β imaging with Pittsburgh compound B and florbetapir: comparing radiotracers and quantification methods SM Landau, C Breault, AD Joshi, M Pontecorvo, CA Mathis, WJ Jagust, ... Journal of Nuclear Medicine 54 (1), 70-77, 2013 | 425 | 2013 |
| Using positron emission tomography and florbetapir F 18 to image cortical amyloid in patients with mild cognitive impairment or dementia due to Alzheimer disease AS Fleisher, K Chen, X Liu, A Roontiva, P Thiyyagura, N Ayutyanont, ... Archives of neurology 68 (11), 1404-1411, 2011 | 398 | 2011 |
| Performance characteristics of amyloid PET with florbetapir F 18 in patients with Alzheimer's disease and cognitively normal subjects AD Joshi, MJ Pontecorvo, CM Clark, AP Carpenter, DL Jennings, ... Journal of Nuclear Medicine 53 (3), 378-384, 2012 | 371 | 2012 |
| Comparing positron emission tomography imaging and cerebrospinal fluid measurements of β‐amyloid SM Landau, M Lu, AD Joshi, M Pontecorvo, MA Mintun, JQ Trojanowski, ... Annals of neurology 74 (6), 826-836, 2013 | 361 | 2013 |
| Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition MJ Pontecorvo, MD Devous Sr, M Navitsky, M Lu, S Salloway, FW Schaerf, ... Brain 140 (3), 748-763, 2017 | 337 | 2017 |
| Individual differences in aging: behavioral and neurobiological correlates AL Markowska, WS Stone, DK Ingram, J Reynolds, PE Gold, LH Conti, ... Neurobiology of aging 10 (1), 31-43, 1989 | 294 | 1989 |
| Selective memory loss following nucleus basalis lesions: long term behavioral recovery despite persistent cholinergic deficiencies RT Bartus, C Flicker, RL Dean, M Pontecorvo, JC Figueiredo, SK Fisher Pharmacology Biochemistry and Behavior 23 (1), 125-135, 1985 | 291 | 1985 |
| Amyloid PET imaging in Alzheimer’s disease: a comparison of three radiotracers SM Landau, BA Thomas, L Thurfjell, M Schmidt, R Margolin, M Mintun, ... European journal of nuclear medicine and molecular imaging 41, 1398-1407, 2014 | 283 | 2014 |
| Positron emission tomography imaging with [18F] flortaucipir and postmortem assessment of Alzheimer disease neuropathologic changes AS Fleisher, MJ Pontecorvo, MD Devous, M Lu, AK Arora, SP Truocchio, ... JAMA neurology 77 (7), 829-839, 2020 | 273 | 2020 |
| Amyloid-β assessed by florbetapir F 18 PET and 18-month cognitive decline: a multicenter study PM Doraiswamy, RA Sperling, RE Coleman, KA Johnson, EM Reiman, ... Neurology 79 (16), 1636-1644, 2012 | 256 | 2012 |
| Apolipoprotein E ε4 and age effects on florbetapir positron emission tomography in healthy aging and Alzheimer disease AS Fleisher, K Chen, X Liu, N Ayutyanont, A Roontiva, P Thiyyagura, ... Neurobiology of aging 34 (1), 1-12, 2013 | 211 | 2013 |
| Tau positron-emission tomography in former national football league players RA Stern, CH Adler, K Chen, M Navitsky, J Luo, DW Dodick, ML Alosco, ... New England journal of medicine 380 (18), 1716-1725, 2019 | 199 | 2019 |
| A multicentre longitudinal study of flortaucipir (18F) in normal ageing, mild cognitive impairment and Alzheimer’s disease dementia MJ Pontecorvo, MD Devous, I Kennedy, M Navitsky, M Lu, N Galante, ... Brain 142 (6), 1723-1735, 2019 | 194 | 2019 |
